| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |